CSPC Attending Beijing-Tianjin-Hebei Pharmaceutical Innovation and Development Conference

On June 18, 2023, the first Beijing-Tianjin-Hebei Pharmaceutical Innovation and Development Conference was held in Xiong'an New Area. The meeting was jointly sponsored by Hebei Pharmaceutical Association, Beijing Pharmaceutical Association, and Tianjin Pharmaceutical Association and co-directed by the Chinese Pharmaceutical Association, Hebei Xiong'an New Area Administrative Committee, and Hebei Association for Science and Technology. As a high-level pharmaceutical innovation and development event in China, the Conference was attended by Bi Jingquan, a member of the Standing Committee of CPPCC and deputy director of the CPPCC Economic Commission, Sun Xianze, chairman of the Chinese Pharmaceutical Association, Zhang Boli, academician of Chinese Academy of Engineering, and other relevant leaders, well-known academicians, experts, and scholars in the domestic pharmaceutical field, leaders of Beijing, Tianjin and Hebei government authorities, and experts and representatives from well-known pharmaceutical enterprises and medical institutions. 

CSPC Pharmaceutical Group ("CSPC"), one of the outstanding pharmaceutical enterprises in the Beijing-Tianjin-Hebei region, participated in the event, displaying the image of the Group in a large booth and from multiple angles. Song Yunlong, general manager of Shanghai Yishi Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the Group, reported on the theme of "R&D and Thinking on Innovative Drugs" during the exhibition and had extensive exchanges with participating experts and industry representatives to discuss the new mode of pharmaceutical innovation and development in Beijing, Tianjin, and Hebei.